期刊文献+

高血压超重或肥胖与血浆内皮素一氧化氮的关系探讨

Study On Relation Between Overweight or Obesity and the Levels of Endothelin and Nitric Oxide in Plasma in Hypertension
下载PDF
导出
摘要 目的:研究高血压患者中超重或肥胖因素对内皮素、一氧化氮的影响。方法:选取高血压患者60例,正常血压对照组32例。根据体重指数将60例高血压患者分为超重或肥胖组(体重指数≥24)和正常体重组(体重指数<24)。采清晨空腹静脉血,测量血浆内皮素和一氧化氮含量。用SPSS统计软件对测定的结果进行统计学处理。结果:高血压组血浆内皮素浓度、一氧化氮浓度较正常对照组有显著性差异(P<0.05);超重或肥胖组血浆内皮素和一氧化氮浓度较正常体重组有显著性差异(P<0.05)。结论:超重或肥胖的高血压患者血浆内皮素和一氧化氮浓度较正常体重高血压患者有显著性差异,说明超重或肥胖对高血压患者内皮功能有明显影响。 Objective:To investigate the influence of overweight or obesity in endothelin (ET) and nitric oxide (NO) in patients with hypertension. Methods:60 patients with hypertension and 32 controls with normal blood pressure were selected, 60 hypertension were divided into two groups according to the body mass index (BMI) :overweight or obesity group (BMI) and normal weight group(BMI〈 24). The levels of ET and NO in plasma were measured. The results were statistically analyzed by SPSS software. Results: There was siganificant differences in the level of ET and NO in plasma between hypertension group and normal blood pressure group (P 〈 0.05) ;or overweight or obesity group and normal weight group ( P 〈 0.05). Conclusions: The hypertension patients with overweight or obesity differs from those with normal weight in the levels of ET and NO in plasma, which indicates that overweight or obesity has effect on function of endothelium.
出处 《内蒙古医学杂志》 2006年第8期697-699,共3页 Inner Mongolia Medical Journal
关键词 高血压 肥胖 内皮素 一氧化氮 Hypertension Obesity Endothelin Nitric oxide
  • 相关文献

参考文献10

二级参考文献36

  • 1冯宁平,叶广俊,邵立新.儿童期心血管病危险因素现状研究[J].中华预防医学杂志,1997,31(1):27-30. 被引量:14
  • 2[1]Verdecchia P,Schillaci G, Porcellati C. Dippers versus non-dippers[J]. J Hypertens 1991,9(8 Suppl) :S42~44.
  • 3[2]Verdechia P, Schillaci G, Guerrieri M, et al. Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension[J].Circulation 1990,81:528~536.
  • 4[3]Loscher IF,Wenzel RR. Endothelin and endothelin antagonists: pharmacology and clinical implications [J]. Agents Actions1995,45 :237~253.
  • 5[4]Moncada S,Palmer RMJ ,Higgs EA. Nitric oxide of physiology, pathophysiology and pharmacology[J]. Pharmaco Rev 1991,43:109.
  • 6[5]O'Brien E, Sheriden J,O'Malley K. Dippers and non-dippers[J]. Lancet 1988,2:397.
  • 7[1]Haynes WG, Webb DJ. [J]. J Hypertens, 1998, 16(8): 1081-1098.
  • 8[2]Hocher B,Thone-Reinecke C,Rohmeiss P, et al. [J].J Clin Invest, 1997,99:1380-1389.
  • 9[3]Radaelli A, Mircoli L, Mori I. [J]. Hypertention,1998,32: 735-739.
  • 10[4]Shiro K, Kensuke E, Chu K, et al. [J]. J Hypertens,2000,18:1795-1800.

共引文献2087

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部